Medidata vs QuantHealth (2026)
Medidata is the trial platform many studies already run on, anchored by Rave data capture. Its AI, packaged since July 2026 as Medidata Plus, covers study build, data review, safety signal detection and a Dot assistant for simulation and forecasting, and the company says it is trained on an anonymized corpus of more than 42,000 trials and 13 million patients. QuantHealth does one thing: trial simulation. It predicts how each patient would respond to an investigational therapy from a knowledge graph of drug biology and a large real world database, then rolls the predictions into a simulated result for protocol, indication and enrollment choices. Both now offer simulation. Medidata's sits inside the platform a study already runs on; QuantHealth's is the whole product, built on patient level response prediction and published against three phase 3 readouts.
- AI across study build, data review and safety signal detection inside Rave.
- Simulation and forecasting through the Dot assistant, beside the platform a study already uses.
- Certification documents published on a public trust page.
- Patient level response prediction rolled into simulated trial results.
- Simulated against actual results published for three phase 3 trials.
- Indication selection, probability of technical success and market forecasting from the same models.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Medidata and QuantHealth are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Medidata | QuantHealth |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Founded | Not recorded | 2020 |
| Headquarters | New York, New York | Tel Aviv, Israel |
| Website | medidata.com | quanthealth.ai |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Medidata, a Dassault Systemes brand based in New York, sells clinical trial software to drug and device sponsors and contract research organizations. The platform is anchored by Rave electronic data capture and spans study build, trial management, patient experience, imaging and data review, with about 2,300 customers.
Source: AI Health Index, September 2026
Clinical trial simulation company with offices in Tel Aviv and Worcester, Massachusetts. Its platform predicts how individual patients would respond to an investigational therapy, drawing on a knowledge graph of drug biology and a real world database the company sizes at 350 million lives, and aggregates those predictions into a simulated trial result so sponsors can test protocol, indication and enrollment choices before a study runs.
Source: AI Health Index, September 2026
Questions buyers ask
How do Medidata and QuantHealth work with the EHR?
Clinical Data Studio brings in non-Medidata sources, including third party laboratories and other data capture systems. Data flows one way, from the record into the trial; no named record system, marketplace listing or integration documentation shows a production connection to a specific EHR, and the exchanges are not named.
With QuantHealth, the company's data framework integrates biomedical, clinical and epidemiological sources on its side. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do Medidata and QuantHealth cover?
The platform serves biopharmaceutical and medtech sponsors and contract research organizations across study design, build, execution and closeout, with therapeutic area solutions in oncology, vaccines and CNS; Health Record Connect also feeds Medidata Surgical Planning and real world data work that reaches beyond trials.
For QuantHealth, the evidence page claims coverage across therapeutic areas, clinical phases and treatment modalities, and case studies span oncology (head and neck, breast, multiple myeloma), inflammatory, metabolic and respiratory disease. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How much do Medidata and QuantHealth leave to the clinician?
For the rest the company says every AI capability has a human in the loop, without describing the checkpoint: whether generated forms, edit checks and synthetic test data from AI study build reach a live study without approval, whether redacted images are sampled or verified, and what the audit-history agent in Medidata Plus may do.
In QuantHealth's case, the results go to clinical development, business development and portfolio teams as virtual trial readouts, enrollment curves and probability of success estimates; nothing is actioned on a patient. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Trials AI page.
Both records were reviewed on this site in September 2026. Neither company publishes a price, and QuantHealth's accuracy figures are measured by the company.
Ask both how their simulated trial results compared with the real ones, and how many predictions that comparison covers.